National Notifiable Diseases Surveillance System, 1 October to 31 December 2017

A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 80,388 notifications to the National Notifiable Diseases Surveillance System (NNDSS) between 1 October to 31 December 2017 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.

Page last updated: 08 March 2018

Office of Health Protection, Department of Health

Table 1: Reporting of notifiable diseases by jurisdiction

Table 1: Reporting of notifiable diseases by jurisdiction
Disease Data received from:
Bloodborne diseases
Hepatitis (NEC) All jurisdictions
Hepatitis B (newly acquired) All jurisdictions
Hepatitis B (unspecified) All jurisdictions
Hepatitis C (newly acquired) All jurisdictions
Hepatitis C (unspecified) All jurisdictions
Hepatitis D All jurisdictions
Gastrointestinal diseases
Botulism All jurisdictions
Campylobacteriosis All jurisdictions except New South Wales
Cryptosporidiosis All jurisdictions
Haemolytic uraemic syndrome All jurisdictions
Hepatitis A All jurisdictions
Hepatitis E All jurisdictions
Listeriosis All jurisdictions
Paratyphoid All jurisdictions
Shiga toxin/verotoxin-producing Escherichia coli All jurisdictions
Salmonellosis All jurisdictions
Shigellosis All jurisdictions
Typhoid fever All jurisdictions
Quarantinable diseases
Avian influenza in humans All jurisdictions
Cholera All jurisdictions
Middle East respiratory syndrome coronavirus All jurisdictions
Plague All jurisdictions
Rabies All jurisdictions
Severe acute respiratory syndrome All jurisdictions
Smallpox All jurisdictions
Viral haemorrhagic fever All jurisdictions
Yellow fever All jurisdictions
Sexually transmissible infections
Chlamydial infection All jurisdictions
Donovanosis All jurisdictions
Gonococcal infection All jurisdictions
Syphilis < 2 years duration All jurisdictions
Syphilis > 2 years or unspecified duration All jurisdictions
Syphilis - congenital All jurisdictions
Vaccine preventable diseases
Diphtheria All jurisdictions
Haemophilus influenzae type b All jurisdictions
Influenza (laboratory confirmed) All jurisdictions
Measles All jurisdictions
Mumps All jurisdictions
Pertussis All jurisdictions
Pneumococcal disease – invasive All jurisdictions
Poliovirus infection All jurisdictions
Rubella All jurisdictions
Rubella - congenital All jurisdictions
Tetanus All jurisdictions
Varicella zoster (chickenpox) All jurisdictions except New South Wales
Varicella zoster (shingles) All jurisdictions except New South Wales
Varicella zoster (unspecified) All jurisdictions except New South Wales
Vectorborne diseases
Barmah Forest virus infection All jurisdictions
Chikungunya virus infection All jurisdictions except Australian Capital Territory
Dengue virus infection All jurisdictions
Flavivirus infection (unspecified) All jurisdictions
Japanese encephalitis virus infection All jurisdictions
Kunjin virus infection All jurisdictions
Malaria All jurisdictions
Murray Valley encephalitis virus infection All jurisdictions
Ross River virus infection All jurisdictions
Zoonoses
Anthrax All jurisdictions
Australian bat lyssavirus infection All jurisdictions
Brucellosis All jurisdictions
Leptospirosis All jurisdictions
Lyssavirus infection (NEC) All jurisdictions
Ornithosis All jurisdictions
Q fever All jurisdictions
Tularaemia All jurisdictions
Other bacterial infections
Legionellosis All jurisdictions
Leprosy All jurisdictions
Meningococcal infection – invasive All jurisdictions
Tuberculosis All jurisdictions
NEC Not elsewhere classified.

Table 2: Notifications of diseases received by state and territory health authorities, 1 October to 31 December 2017, by date of diagnosis*

Table 2: Notifications of diseases received by state and territory health authorities, 1 October to 31 December 2017, by date of diagnosis*
Disease ACT NSW NT QLD SA TAS VIC WA Total current quarter Total last quarter Total same period previous year Last 5 years mean current quarter Ratio Year to date Last 5 years YTD mean
Bloodborne diseases
Hepatitis B (newly acquired) † 0 5 0 8 2 1 8 8 32 33 37 39 0.8 141 167.4
Hepatitis B (unspecified) ‡ 17 553 29 201 72 11 416 126 1,425 1,482 1,411 1,544 0.9 5,967 6,446.2
Hepatitis C (newly acquired) † 2 13 0 85 6 5 11 34 156 147 186 157.8 1 610 625.6
Hepatitis C (unspecified) ‡ 31 1,041 37 517 82 61 425 266 2,460 2,533 2,796 2,532 1 10,089 10,038.2
Hepatitis D 0 6 0 1 5 0 4 0 16 26 15 12.8 1.3 64 51.2
Gastrointestinal diseases
Botulism 0 1 0 0 1 0 0 0 2 0 0 0.2 10 2 1.6
Campylobacteriosis 142 NN 73 2,139 789 221 1,807 932 6,103 4,999 6,993 5,545.8 1.1 22,385 19,411
Cryptosporidiosis 2 136 17 157 28 12 234 28 614 516 952 708.4 0.9 4,683 3,776.8
Haemolytic uraemic syndrome (HUS) 0 0 0 0 2 0 1 0 3 1 6 4.8 0.6 14 18
Hepatitis A 0 22 0 7 15 0 35 1 80 60 41 41.8 1.9 211 182.2
Hepatitis E 0 4 0 1 0 0 2 0 7 10 15 13.2 0.5 47 41.6
Listeriosis 1 6 0 2 1 0 5 0 15 13 21 21.2 0.7 70 80.6
Paratyphoid 2 10 0 1 2 0 8 0 23 9 17 19.2 1.2 66 75.4
STEC § 0 14 0 7 85 1 12 22 141 116 146 56.2 2.5 490 176.8
Salmonellosis 33 834 137 883 407 96 776 558 3,724 2,569 3,872 3,623.4 1 16,438 15,038.2
Shigellosis 2 65 137 58 20 8 162 69 521 429 362 230 2.3 1,757 913.6
Typhoid Fever 0 10 0 2 1 0 10 10 33 23 25 29.2 1.1 141 121.4
Quarantinable diseases
Avian influenza in humans (AIH) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cholera 0 1 0 0 0 0 0 0 1 1 1 0.8 1.3 2 2.6
Middle East respiratory syndrome coronavirus (MERS-CoV) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Plague 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Rabies 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Severe acute respiratory syndrome (SARS) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Smallpox 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Viral haemorrhagic fever (NEC) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Yellow fever 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sexually transmissible infections
Chlamydial infection ||, 369 7,171 678 5,497 1,368 339 2,944 2,702 21,068 22,798 22,586 20,921.8 1 96,352 86,947.2
Donovanosis 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4
Gonococcal infection 73 2,266 457 1,139 312 24 1,758 646 6,675 6,713 6,216 4,361.8 1.5 28,411 17,377.4
Syphilis < 2 years 8 265 81 250 40 2 324 87 1,057 1,127 833 587 1.8 4,347 2,319.4
Syphilis > 2 years or unspecified duration ‡, 2 137 22 68 21 0 186 48 484 511 491 429 1.1 2,027 1,779
Syphilis congenital 0 1 0 1 0 0 0 0 2 2 0 0.4 5 8 3.2
Vaccine preventable diseases
Diphtheria 0 0 0 1 0 0 1 1 3 1 3 1 3 8 3
Haemophilus influenzae type b 0 4 1 1 0 0 0 0 6 3 3 3.6 1.7 15 18
Influenza (laboratory confirmed) 272 4,927 223 5,195 4,248 311 4,582 1,464 21,222 207,263 15,034 7,505.8 2.8 249,787 66,406.8
Measles 2 4 0 0 0 0 3 0 9 20 29 38.2 0.2 81 173.8
Mumps 0 37 27 138 3 2 10 5 222 219 110 103.6 2.1 809 410.6
Pertussis 23 1,083 32 337 360 15 517 412 2,779 3,099 5,571 5,532.6 0.5 12,118 18,195.2
Pneumococcal disease (invasive) 9 143 14 59 43 12 106 32 418 870 396 351.4 1.2 2,040 1,620.2
Poliovirus infection 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Rotavirus 0 739 7 527 558 87 0 97 2,015 2,850 855 1,110.6 1.8 7,001 3,316
Rubella 0 1 0 0 0 0 0 0 1 3 1 4.4 0.2 11 21.8
Rubella congenital 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.8
Tetanus 0 0 0 1 0 0 0 0 1 0 1 1.6 0.6 4 4.6
Varicella zoster (chickenpox) 42 NN 17 182 134 13 349 178 915 854 1,001 702.6 1.3 3,153 2,349.4
Varicella zoster (shingles) 82 NN 95 554 662 104 667 508 2,672 2,142 2,106 1,558 1.7 9,128 5,771.2
Varicella zoster (unspecified) 49 NN 1 1,364 93 43 1,784 401 3,735 4,088 3,983 3,303.8 1.1 15,839 12,353.6
Vectorborne diseases
Barmah Forest virus infection 0 22 2 64 1 0 2 16 107 81 68 275 0.4 448 1,533.2
Chikungunya virus infection 0 10 0 3 0 0 10 2 25 31 47 25.8 1 98 97.6
Dengue virus infection 16 87 3 36 6 4 39 33 224 190 339 290.8 0.8 1,070 1,810.8
Flavivirus infection (unspecified) 0 0 0 1 0 0 0 0 1 0 14 4.2 0.2 15 33.6
Japanese encephalitis virus infection 0 0 0 0 0 0 0 0 0 0 0 0.2 0 1 1.8
Malaria 2 11 0 28 1 2 18 7 69 95 76 76.6 0.9 359 325.8
Murray Valley encephalitis virus infection 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6
Ross River virus infection 0 121 27 202 13 0 34 165 562 578 1,183 1,085.2 0.5 6,913 5,516.8
West Nile/Kunjin virus infection 0 0 0 0 0 0 0 0 0 2 0 0.6 0 6 0.8
Zoonoses
Anthrax 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Australian bat lyssavirus infection 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2
Brucellosis 0 4 0 4 0 0 0 0 8 3 5 4.6 1.7 18 19.8
Leptospirosis 0 2 2 12 0 0 1 1 18 32 21 15.6 1.2 142 95
Lyssavirus infection (NEC) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Ornithosis 0 0 0 0 0 0 6 0 6 5 13 16.4 0.4 21 40.4
Q fever 0 41 1 43 7 2 6 2 102 98 149 121.6 0.8 454 498.8
Tularaemia 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other bacterial infections
Legionellosis 0 33 0 21 9 1 36 12 112 71 97 104.2 1.1 385 409.8
Leprosy 0 1 0 2 1 0 0 1 5 2 6 3.6 1.4 10 13.2
Meningococcal disease (invasive)** 0 20 13 16 5 6 24 19 103 141 82 48.6 2.1 382 194.4
Tuberculosis 3 144 7 51 12 3 136 50 406 361 389 363.2 1.1 1,416 1,307.2
1,184 19,995 2,140 19,866 9,415 1,386 17,459 8,943 80,388 267,220 78,604 506,054
*The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.
†Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland began reporting hepatitis C newly acquired from 1 September 2016. Previous notifications are reported under hepatitis unspecified.
‡ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.
§ Infection with Shiga toxin/verotoxin-producing Escherichia coli.
|| Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens.
The national case definitions for chlamydia, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).
** Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.
NN Not notifiable
NEC Not elsewhere classified
Totals comprise data from all states and territories. Cumulative figures are subject to retrospective revision so there may be discrepancies between the number of new notifications and the increment in the cumulative figure from the previous period.
Table 3: Notification rates of diseases, 1 October to 31 December 2017, by state or territory. (Annualised rate per 100,000 population)*,†
Table 3: Notification rates of diseases, 1 October to 31 December 2017, by state or territory. (Annualised rate per 100,000 population)*,†
1Disease ACT NSW NT QLD SA TAS VIC WA Australia
Bloodborne diseases
Hepatitis B (newly acquired) ‡ 0.0 0.3 0.0 0.7 0.5 0.8 0.5 1.3 0.5
Hepatitis B (unspecified) § 16.9 28.6 47.2 16.6 16.8 8.5 26.9 19.7 23.5
Hepatitis C (newly acquired) ‡ 2.0 0.7 0.0 7.0 1.4 3.9 0.7 5.3 2.6
Hepatitis C (unspecified) § 30.7 53.8 60.2 42.6 19.1 47.1 27.5 41.6 40.6
Hepatitis D 0.0 0.3 0.0 0.1 1.2 0.0 0.3 0.0 0.3
Gastrointestinal diseases
Botulism 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0
Campylobacteriosis 140.8 NN 118.8 176.5 184.2 170.8 117.0 145.7 148.2
Cryptosporidiosis 2.0 7.0 27.7 13.0 6.5 9.3 15.1 4.4 10.1
Haemolytic uraemic syndrome (HUS) 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0
Hepatitis A 0.0 1.1 0.0 0.6 3.5 0.0 2.3 0.2 1.3
Hepatitis E 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1
Listeriosis 1.0 0.3 0.0 0.2 0.2 0.0 0.3 0.0 0.2
Paratyphoid 2.0 0.5 0.0 0.1 0.5 0.0 0.5 0.0 0.4
STEC || 0.0 0.7 0.0 0.6 19.8 0.8 0.8 3.4 2.3
Salmonellosis 32.7 43.1 223.0 72.8 95.0 74.2 50.2 87.2 61.5
Shigellosis 2.0 3.4 223.0 4.8 4.7 6.2 10.5 10.8 8.6
Typhoid Fever 0.0 0.5 0.0 0.2 0.2 0.0 0.6 1.6 0.5
Quarantinable diseases
Avian influenza in humans (AIH) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cholera 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Middle East respiratory syndrome coronavirus (MERS-CoV) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Plague 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Rabies 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Severe acute respiratory syndrome (SARS) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Smallpox 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Viral haemorrhagic fever (NEC) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Yellow fever 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Sexually transmissible infections
Chlamydial infection ¶** 365.8 370.6 1,103.6 453.5 319.4 262.0 190.6 422.4 348.1
Donovanosis 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Gonococcal infection** 72.4 117.1 743.9 94.0 72.9 18.5 113.8 101.0 110.3
Syphilis < 2 years ** 7.9 13.7 131.8 20.6 9.3 1.5 21.0 13.6 17.5
Syphilis > 2 years or unspecified duration §** 2.0 7.1 35.8 5.6 4.9 0.0 12.0 7.5 8.0
Syphilis congenital 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0
2Vaccine preventable diseases
Diphtheria 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0
Haemophilus influenzae type b 0.0 0.2 1.6 0.1 0.0 0.0 0.0 0.0 0.1
Influenza (laboratory confirmed) 269.7 254.6 363.0 428.6 991.9 240.3 296.6 228.8 350.6
Measles 2.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1
Mumps 0.0 1.9 43.9 11.4 0.7 1.5 0.6 0.8 3.7
Pertussis 22.8 56.0 52.1 27.8 84.1 11.6 33.5 64.4 45.9
Pneumococcal disease (invasive) 8.9 7.4 22.8 4.9 10.0 9.3 6.9 5.0 6.9
Poliovirus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Rotavirus 0.0 38.2 11.4 43.5 130.3 67.2 0.0 15.2 33.3
Rubella 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Rubella congenital 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Tetanus 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0
Varicella zoster (chickenpox) 41.6 NN 27.7 15.0 31.3 10.0 22.6 27.8 22.2
Varicella zoster (shingles) 81.3 NN 154.6 45.7 154.6 80.4 43.2 79.4 64.9
Varicella zoster (unspecified) 48.6 NN 1.6 112.5 21.7 33.2 115.5 62.7 90.7
Vectorborne diseases
Barmah Forest virus infection 0.0 1.1 3.3 5.3 0.2 0.0 0.1 2.5 1.8
Chikungunya virus infection 0.0 0.5 0.0 0.2 0.0 0.0 0.6 0.3 0.4
Dengue virus infection 15.9 4.5 4.9 3.0 1.4 3.1 2.5 5.2 3.7
Flavivirus infection (unspecified) 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0
Japanese encephalitis virus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Malaria 2.0 0.6 0.0 2.3 0.2 1.5 1.2 1.1 1.1
Murray Valley encephalitis virus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ross River virus infection 0.0 6.3 43.9 16.7 3.0 0.0 2.2 25.8 9.3
West Nile/Kunjin virus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Zoonoses
Anthrax 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Australian bat lyssavirus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Brucellosis 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1
Leptospirosis 0.0 0.1 3.3 1.0 0.0 0.0 0.1 0.2 0.3
Lyssavirus infection (NEC) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ornithosis 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1
Q fever 0.0 2.1 1.6 3.5 1.6 1.5 0.4 0.3 1.7
Tularaemia 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other bacterial infections
Legionellosis 0.0 1.7 0.0 1.7 2.1 0.8 2.3 1.9 1.9
Leprosy 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.2 0.1
Meningococcal disease (invasive)††

0.0

1.0

21.2

1.3

1.2

4.6

1.6

3.0

1.7

Tuberculosis

3.0

7.4

11.4

4.2

2.8

2.3

8.8

7.8

6.7
*The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.
†Rate per 100,000 of population. Annualisation Factor was 4.0
‡Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland began reporting hepatitis C newly acquired from 1 September 2016. Previous notifications are reported under hepatitis unspecified.
§Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.
||Infection with Shiga toxin/verotoxin-producing Escherichia coli.
Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens.
**The national case definitions for chlamydia, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).
††Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.
NEC Not elsewhere classified.
NN Not notifiable.

In this section